129 related articles for article (PubMed ID: 31960968)
1. Ursodeoxycholic acid attenuates the expression of proinflammatory cytokines in periodontal cells.
Talebian R; Panahipour L; Gruber R
J Periodontol; 2020 Aug; 91(8):1098-1104. PubMed ID: 31960968
[TBL] [Abstract][Full Text] [Related]
2. Taurocholic acid lowers the inflammatory response of gingival fibroblasts, epithelial cells, and macrophages.
Talebian R; Hashem O; Gruber R
J Oral Sci; 2020; 62(3):335-339. PubMed ID: 32581181
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages.
Ko WK; Lee SH; Kim SJ; Jo MJ; Kumar H; Han IB; Sohn S
PLoS One; 2017; 12(6):e0180673. PubMed ID: 28665991
[TBL] [Abstract][Full Text] [Related]
4. Oral squamous carcinoma cell lysates provoke exacerbated inflammatory response in gingival fibroblasts.
Sordi MB; Panahipour L; Gruber R
Clin Oral Investig; 2023 Aug; 27(8):4785-4794. PubMed ID: 37391526
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
Ludwig JM; Zhang Y; Chamulitrat W; Stremmel W; Pathil A
PLoS One; 2018; 13(5):e0197836. PubMed ID: 29795632
[TBL] [Abstract][Full Text] [Related]
6. Proof-of-Principle Study Suggesting Potential Anti-Inflammatory Activity of Butyrate and Propionate in Periodontal Cells.
Santos AFP; Cervantes LCC; Panahipour L; Souza FÁ; Gruber R
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232340
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.
Pang L; Zhao X; Liu W; Deng J; Tan X; Qiu L
Nutrients; 2015 May; 7(5):3200-18. PubMed ID: 25951128
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
9. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid inhibits TNFα-induced IL-8 release from monocytes.
O'Dwyer AM; Lajczak NK; Keyes JA; Ward JB; Greene CM; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G334-41. PubMed ID: 27340129
[TBL] [Abstract][Full Text] [Related]
11. Profiling of inflammatory cytokines produced by gingival fibroblasts after human cytomegalovirus infection.
Botero JE; Contreras A; Parra B
Oral Microbiol Immunol; 2008 Aug; 23(4):291-8. PubMed ID: 18582328
[TBL] [Abstract][Full Text] [Related]
12. Dalbergiones lower the inflammatory response in oral cells in vitro.
Shao F; Panahipour L; Omerbasic A; Tang F; Gruber R
Clin Oral Investig; 2022 Aug; 26(8):5419-5428. PubMed ID: 35505200
[TBL] [Abstract][Full Text] [Related]
13. Blocking of Caspases Exerts Anti-Inflammatory Effects on Periodontal Cells.
Panahipour L; Cervantes LCC; Oladzad Abbasabadi A; Sordi MB; Kargarpour Z; Gruber R
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888133
[TBL] [Abstract][Full Text] [Related]
14. Hypoallergenic infant formula lacks transforming growth factor beta activity and has a lower anti-inflammatory activity than regular infant formula.
Panahipour L; Tabatabaei AA; Gruber R
J Dairy Sci; 2020 Aug; 103(8):6771-6781. PubMed ID: 32505409
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholyl lysophosphatidylethanolamide negatively regulates TLR-mediated lipopolysaccharide response in human THP-1-derived macrophages.
Horvatova A; Utaipan T; Otto AC; Zhang Y; Gan-Schreier H; Pavek P; Pathil A; Stremmel W; Chamulitrat W
Eur J Pharmacol; 2018 Apr; 825():63-74. PubMed ID: 29475064
[TBL] [Abstract][Full Text] [Related]
16. Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts.
Abidi AH; Abhyankar V; Alghamdi SS; Tipton DA; Dabbous M
J Periodontal Res; 2022 Dec; 57(6):1127-1138. PubMed ID: 36070347
[TBL] [Abstract][Full Text] [Related]
17. Role for Lipids Secreted by Irradiated Peripheral Blood Mononuclear Cells in Inflammatory Resolution in Vitro.
Panahipour L; Kochergina E; Laggner M; Zimmermann M; Mildner M; Ankersmit HJ; Gruber R
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630157
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic Acid Inhibits Inflammatory Responses and Promotes Functional Recovery After Spinal Cord Injury in Rats.
Ko WK; Kim SJ; Jo MJ; Choi H; Lee D; Kwon IK; Lee SH; Han IB; Sohn S
Mol Neurobiol; 2019 Jan; 56(1):267-277. PubMed ID: 29691718
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy.
Ye HL; Zhang JW; Chen XZ; Wu PB; Chen L; Zhang G
Life Sci; 2020 Feb; 242():117175. PubMed ID: 31843528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
